Home › Research › Topics › Mild cognitive impairment › ADNI baseline cognition
Baseline cognition adds the most to an MCI conversion model
Adding baseline cognitive scores lifted Harrell's C from 0.635 to 0.847, a gain of 0.213 (95% CI 0.163–0.267). On top of every biomarker in the multimodal model, cognition still added 0.057.
Figures are derived from ADNI data under a Data Use Agreement. Only aggregate statistics are published; no individual participant records are shown.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is funded by the National Institute on Aging and contributions. This page is not endorsed by ADNI or the National Institute on Aging.
Cognitive tests are the cheapest measurement in the whole cohort. They need a table, a pencil and an hour, not a lumbar puncture or a PET scanner. This page asks how much they add to a model that predicts who will convert from mild cognitive impairment to dementia. Discrimination is measured with Harrell's C, where 0.5 is chance and 1.0 is perfect.
Before and after adding cognition
Harrell's C for the conversion model without and with baseline cognitive scores.
- 0.635C without cognitive scores
- 0.847C with cognitive scores
- +0.213gain (95% CI +0.163–+0.267)
- +0.057gain beyond all biomarkers combined
What this means
The gain of 0.213 is the largest single improvement in any of the ADNI models on this site. Its 95% CI runs from 0.163 to 0.267, so even the low end is a clear improvement.
The second number is the one that matters for practice. The multimodal model already holds CSF, MRI and amyloid PET. Put baseline cognition on top of all of that and C still rises by 0.057. Cognitive scores carry information the biomarkers do not, and the reverse is also true: the biomarkers are not made redundant by the tests.
← Mild cognitive impairment: the research library
- Related ADNI analyses: conversion rates and single markers · the multimodal model · how the measures correlate
Figures are derived from ADNI data under a Data Use Agreement. Only aggregate statistics are published; no individual participant records are shown.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is funded by the National Institute on Aging and contributions. This page is not endorsed by ADNI or the National Institute on Aging.